Macro Challenges Make Calls On Newly Resilient Medtechs

Health Care Transition Accelerates And Sustainability Compliance Is Demanding Attention

04 Dec 2023

Global medtechs had a big enough challenge with COVID-19 and its aftermath before the full-scale regional conflict in Ukraine added more uncertainty to the question of when market normality would return.

For medtechs, 2022 will be remembered as one of the most challenging years the industry has seen in decades. The COVID-19 pandemic continued to impact operations for much of the year – especially in China – and disrupted supply chains. In addition, soaring inflation and rising interest rates combined to test the industry’s resilience and drag a big shadow over the global economic outlook.

That was how the ostomy and wound care products company Coloplast Ltd. described the events of 2021-2022. But these...